Ledger.Open graph →
SEC Form D · filed October 21, 2020

InCarda Therapeutics, Inc

Offering
$50.0M
Sold
$28.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Greg Wasson · ORLANDO, FLDirectorMark Simo · Carlsbad, CADirectorBrian Simo · Carlsbad, CADirectorRichard Brenner · ORLANDO, FLDirectorMichael Otworth · ORLANDO, FLDirectorAndrew Elbardissi · NEWARK, CADirectorDan Welch · NEWARK, CADirectorJames Donnally · ORLANDO, FLDirectorJohan Christenson · NEWARK, CADirectorGrace Colon · NEWARK, CAExec · DirectorBoris Said · Carlsbad, CAExec · DirectorAlan Colowick · NEWARK, CADirectorJonathan Ghitis · Aventura, FLDirectorIsaac Cheng · Cambridge, MADirectorIsaac Cheng · Charlestown, MADirectorArun Kurichety · Irvine, CADirectorEarl Jones · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗